Vice President, Development and External Relations:
Anna Eliasson Schamis
aeliasson@acus.org
202-778-4960

Director for Board and Corporate Relations:
Michael Safinaik
msafianik@acus.org
202-778-4945

Director for Membership Programs:
Elena Pak
epak@acus.org
202-778-4967

Director of Finance and Administration:
Drew Ann Jubert
dajubert@acus.org
202-778-4953


Dr. Daniel Vasella 

Daniel Vasella, MD, is Chairman and Chief Executive Officer (CEO) of Novartis AG. He was appointed Chairman in April 1999, having served as CEO and Head of the Group Executive Committee since the merger that created Novartis in 1996.

As the first CEO of Novartis, Dr. Vasella had a leading role in the merger of Sandoz and Ciba-Geigy. Under Dr. Vasella, Novartis has strategically focused the business onhealthcare with Pharmaceuticals as its core.

During his tenure as Chairman and CEO, Dr. Vasella has enhanced the company’scorporate governance policies in line with best practices and listed Novartis on the New York Stock Exchange. He has also strengthened Novartis’ research capacity in leading technologies, establishing The Genomics Institute of The Novartis Research Foundation, which is focused on developing therapeutics from the data generated from the mapping of the human genome, and by moving Novartis' research headquarters to Cambridge(Mass., USA), close to top scientific talent and patient and hospital networks.

Dr. Vasella has also implemented strong pioneering initiatives to ensure access tomedicines such as: the Patient Assistance Program for Novartis’ breakthrough cancer drug Glivec®//Gleevec™, the agreement to supply Novartis’ novel malaria treatment Coartem®at cost to the World Health Organization, and the pledge to donate the drug therapy needed to eradicate leprosy worldwide. Furthermore, on Dr. Vasella’s instigation, Novartis subscribed to the UN Global Compact initiative.

Before the Novartis merger, Daniel Vasella was Chief Executive Officer of Sandoz Pharma Ltd. and a member of the Sandoz Group Executive Committee. From 1988 to 1992 he was with Sandoz Pharmaceuticals Corporation in the US, prior to which he held a number of medical positions in Switzerland.

Dr. Vasella is a member of the Board of Directors of PepsiCo Inc. and of the Chairman’s Council of DaimlerChrysler. He chairs the International Business Leaders Advisory Council for the Mayor of Shanghai and is also a member of the International Board of Governors of the Peres Center for Peace. In 2002 Dr. Vasella was awarded an honorary doctorate by the Faculty of Medicine of the University of Basel.

Dr. Vasella was born in 1953, is married and has three children.

Print This Page
Email This Page